Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 109732314 | 10973231 | 4 | F | 20141215 | 20160802 | 20150401 | 20160809 | EXP | DE-ABBVIE-15K-062-1366915-00 | ABBVIE | 77.99 | YR | F | Y | 0.00000 | 20160809 | CN | COUNTRY NOT SPECIFIED | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 109732314 | 10973231 | 1 | PS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | Y | UNKNOWN | 125057 | 40 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | ||||||
| 109732314 | 10973231 | 2 | SS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | Y | UNKNOWN | 125057 | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | ||||||||
| 109732314 | 10973231 | 3 | SS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | Y | UNKNOWN | 125057 | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | ||||||||
| 109732314 | 10973231 | 4 | C | INSULIN | INSULIN NOS | 1 | 0 | ||||||||||||
| 109732314 | 10973231 | 5 | C | TILIDIN | NALOXONE HYDROCHLORIDETILIDINE HYDROCHLORIDE | 1 | 50/4 | 0 | TID | ||||||||||
| 109732314 | 10973231 | 6 | C | NOVALGIN | METAMIZOLE SODIUM | 1 | 0 | 600 | MG | QID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 109732314 | 10973231 | 1 | Rheumatoid arthritis |
| 109732314 | 10973231 | 4 | Product used for unknown indication |
| 109732314 | 10973231 | 5 | Product used for unknown indication |
| 109732314 | 10973231 | 6 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 109732314 | 10973231 | OT |
| 109732314 | 10973231 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 109732314 | 10973231 | Ascites | |
| 109732314 | 10973231 | Cholelithiasis | |
| 109732314 | 10973231 | Herpes zoster | |
| 109732314 | 10973231 | Malaise | |
| 109732314 | 10973231 | Oedema peripheral | |
| 109732314 | 10973231 | Renal failure | |
| 109732314 | 10973231 | Renal function test abnormal |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 109732314 | 10973231 | 1 | 20110401 | 20150106 | 0 | |
| 109732314 | 10973231 | 2 | 2015 | 201508 | 0 | |
| 109732314 | 10973231 | 3 | 2015 | 201511 | 0 | |
| 109732314 | 10973231 | 5 | 201511 | 0 |